Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove Ads
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards




share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

BCPS study guide

Hepatitis C

QuestionAnswer
definition of chronic HCV infection presence of viral RNA in serum for 6 months or more
RVR Rapid virological response - undetectable HCV RNA at week 4 of treatment
EVR Early virological response - >2 log reduction in HCV RNA compared with baseline or undetectable HCV RNA at 12 weeks
ETR end of treatment response - undetectable HCV RNA at the end of a 24 or 48 week course, depending on genotype
SVR sustained virologic response - undetectable HCV RNA 24 weeks after finishing treatment
recommended initial treatment for acute infection interferon preferably PEG interferon. treat for 12-24 weeks. may add ribavirin but not proven to improve SVR. alternatively can wait to see if pt has spontaneous resolution.
treatment goal for treatment of acute infection vs chronic infection for acute goal is to prevent chronic infection. for chronic infection goal is to achieve SVR
ADEs associated with ribavirin hemolytic anemia - requires dose adjustment and may require colony stimulating factors. riba rage, pancreatitis, pulmonary toxicity, insomnia, irritability. preggers category X.
treatment of chronic HCV infection. ribavirin and protease inhibitors. or NS5B polymerase inhibitor ex. sofosbuvir (Sovaldi) but depends on genotype. now sofosbuvir in all first line treatments
genotype 1 HCV treatment - first line interferon/ribavirin and sofosbuvir or sofosbuvir, ribavirin and simeprevir. treat for 12 weeks
genotype 2/3 HCV treatment - first line sofosbuvir + ribavirin type 2 treat for 12 weeks, type 3 treat for 24 weeks
genotype 4 HCV treatment - first line interferon/ribavirin and sofosbuvir and treat for 12 weeks or sofosbuvir and ribavirin treat for 24 weeks
genotype 5/6 HCV treatment - first line sofosbuvir and peg/ribavirin for 12 weeks
the new AASLD/IDSA guidelines have removed the previous protease inhibitor therapies in favor of sofosbuvir but if genotype I pts were already on these treatment regimens prior to 2014 guidelines what should guide therapy? HCV RNA at wks 4 and 24. if undetectable in most cases continue trt and extend for up to 48 wks depending on whether pt is trt naive or previously responded or relapsed. if HCV RNA >100 at wk 12 or detectable at wk 24 d/c all three drugs if bocepravir
Created by: mjuhlin